Research progress in anti-inflammatory activity of insect antimicrobial peptides and anti-inflammatory mechanism based on signal pathway

doi:10.11958/20212862

Abstract

Abstract:

Insect antimicrobial peptides are the general name of immune active substances produced by insects to resist the infection of external pathogenic microorganisms. Their excellent anti-inflammatory activity makes them have broad application prospects. In this paper, the anti-inflammatory activities and their possible signaling pathways of different insect antimicrobial peptides were reviewed, and the current status of clinical research on insect antimicrobial peptides was introduced, in order to provide references for the application of insect antimicrobial peptides.

Key words: anti-inflammatory drugs (TCD), antimicrobial peptide, insect, signaling pathway, anti-inflammatory activity

CLC Number:

R392.9

References 61

[1]	MUTHUSAMI S, RAMACHANDRAN I K, BABU K N, et al. Role of inflammation in the development of colorectal cancer[J]. Endocr Metab Immune Disord Drug Targets, 2021, 21(1):77-90. doi: 10.2174/1871530320666200909092908.
[2]	RIMA M, RIMA M, FAJLOUN Z, et al. Antimicrobial peptides:A potent alternative to antibiotics[J]. Antibiotics(Basel), 2021, 10(9):1095. doi: 10.3390/antibiotics10091095.
[3]	SAHOO A, SWAIN S S, BEHERA A, et al. Antimicrobial peptides derived from insects offer a novel therapeutic option to combat biofilm: a review[J]. Front Microbiol, 2021, 12:661195. doi: 10.3389/fmicb.2021.661195.
[4]	FENG M, FEI S, XIA J, et al. Antimicrobial peptides as potential antiviral factors in insect antiviral immune response[J]. Front Immunol, 2020, 11:2030. doi: 10.3389/fimmu.2020.02030.
[5]	ZIAJA M, DZIEDZIC A, SZAFRANIEC K, et al. Cecropins in cancer therapies-where we have been[J]. Eur J Pharmacol, 2020, 882:173317. doi: 10.1016/j.ejphar.2020.173317.
[6]	MANNIELLO M D, MORETTA A, SALVIA R, et al. Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance[J]. Cell Mol Life Sci, 2021, 78(9):4259-4282. doi: 10.1007/s00018-021-03784-z.
[7]	ZHAI Z, ZHANG F, CAO R, et al. Cecropin A alleviates inflammation through modulating the gut microbiota of C57BL/6 mice with DSS-induced IBD[J]. Front Microbiol, 2019, 10:1595. doi: 10.3389/fmicb.2019.01595.
[8]	ZHAI Z, NI X, JIN C, et al. Cecropin A modulates tight junction-related protein expression and enhances the barrier function of porcine intestinal epithelial cells by suppressing the MEK/ERK pathway[J]. Int J Mol Sci, 2018, 19(7):1941. doi: 10.3390/ijms19071941.
[9]	ZHANG L, GUI S, LIANG Z, et al. Musca domestica cecropin(Mdc) alleviates Salmonella typhimurium-induced colonic mucosal barrier impairment: associating with inflammatory and oxidative stress response, tight junction as well as intestinal flora[J]. Front Microbiol, 2019, 10:522. doi: 10.3389/fmicb.2019.00522.
[10]	ZHANG L, GUI S, XU Y, et al. Colon tissue-accumulating mesoporous carbon nanoparticles loaded with Musca domestica cecropin for ulcerative colitis therapy[J]. Theranostics, 2021, 11(7):3417-3438. doi: 10.7150/thno.53105.
[11]	SHIN Y P, LEE J H, KIM I W, et al. Anti-inflammatory activity of antimicrobial peptide Papiliocin 3 derived from the swallowtail butterfly, Papilio xuthus[J]. J Life Sci, 2020, 30(10):886-895. doi: 10.5352/JLS.2020.30.10.886.
[12]	HENAO-ARIAS D C, TORO L J, TELLEZ-RAMIREZ G A, et al. Novel antimicrobial cecropins derived from O. curvicornis and D. satanas dung beetles[J]. Peptides, 2021, 145:170626. doi: 10.1016/j.peptides.2021.170626.
[13]	LEE H J, SEO M, BAEK M, et al. Inhibitory effect of Protaetiamycine 6 on neuroinflammation in LPS-stimulated BV-2 microglia[J]. J Life Sci, 2020, 30(12):1078-1084. doi: 10.5352/JLS.2020.30.12.1078.
[14]	KRISHNAN M, CHOI J, JANG A, et al. A novel peptide antibiotic, Pro10-1D, designed from insect defensin shows antibacterial and anti-inflammatory activities in sepsis models[J]. Int J Mol Sci, 2020, 21(17):6216. doi: 10.3390/ijms21176216.
[15]	MA X, YANG N, MAO R, et al. The pharmacodynamics study of insect defensin DLP4 against toxigenic Staphylococcus hyicus ACCC 61734 in vitro and vivo[J]. Front Cell Infect Microbiol, 2021, 11:638598. doi: 10.3389/fcimb.2021.638598.
[16]	LI B, YANG N, WANG X, et al. An enhanced variant designed from DLP4 cationic peptide against Staphylococcus aureus CVCC 546[J]. Front Microbiol, 2020, 11:1057. doi: 10.3389/fmicb.2020.01057.
[17]	BERTRAMS W, LINDHAUER N S, RIEKE M C, et al. Tribolium castaneum defensin 1 kills Moraxella catarrhalisin an in vitro infection model but does not harm commensal bacteria[J]. Virulence, 2021, 12(1):1003-1010. doi: 10.1080/21505594.2021. 1908741.
[18]	JANTARUK P, ROYTRAKUL S, SITTHISAK S, et al. Potential role of an antimicrobial peptide, KLK in inhibiting lipopolysaccharide-induced macrophage inflammation[J]. PLoS One, 2017, 12(8):e0183852. doi: 10.1371/journal.pone.0183852.
[19]	LEE E, KIM J K, SHIN S, et al. Insight into the antimicrobial activities of coprisin isolated from the dung beetle, Copris tripartitus, revealed by structure-activity relationships[J]. Biochim Biophys Acta, 2013, 1828(2):271-283. doi: 10.1016/j.bbamem.2012.10.028.
[20]	陈文凤, 王红芳, 刘振国, 等. 中华蜜蜂Apidaecin的重组表达及其抗菌活性[J]. 中国农业科学, 2019, 52(4):767-776.
	CHEN W F, WANG H F, LIU Z G, et al. Recombinant expression and antimicrobial activity of Apidaecin in Apis cerana cerana[J]. Scientia Agricultura Sinica, 2019, 52(4):767-776. doi: 10.3864/j.issn.0578-1752.2019.04.016
[21]	KRIEGER A K, KNAPPE D, ÖHLMANN S, et al. Proline-rich antimicrobial peptide Api137 is bactericidal in porcine blood infected ex vivo with a porcine or human Klebsiella pneumoniae strain[J]. J Glob Antimicrob Resist, 2021, 24:127-135. doi: 10.1016/j.jgar.2020.12.012.
[22]	LIN Q, SU G, WU A, et al. Bombyx mori gloverin A2 alleviates enterotoxigenic Escherichia coli-induced inflammation and intestinal mucosa disruption[J]. Antimicrob Resist Infect Control, 2019, 8:189. doi: 10.1186/s13756-019-0651-y.
[23]	LIN Q, FU Q, SU G, et al. Protective effect of Bombyx mori gloverin on intestinal epithelial cells exposure to enterotoxigenic E. coli[J]. Braz J Microbiol, 2021, 52(3):1235-1245. doi: 10.1007/s42770-021-00532-0.
[24]	KUMAR V. Going, Toll-like receptors in skin inflammation and inflammatory diseases[J]. Excli J, 2021, 20:52-79. doi: 10.17179/excli2020-3114.
[25]	CZERWINSKA-BLASZCZYK A, PAWLAK E, PAWLOWSKI T. The sgnificance of Toll-like receptors in the neuroimmunologic background of alcohol dependence[J]. Front Psychiatry, 2022, 12:797123. doi: 10.3389/fpsyt.2021.797123.
[26]	ADHIKARLA S V, JHA N K, GOSWAMI V K, et al. TLR-mediated signal transduction and neurodegenerative disorders[J]. Brain Sci, 2021, 11(11):1373. doi: 10.3390/brainsci11111373.
[27]	AHMEDY O A, IBRAHIM S M, SALEM H H, et al. Antiulcerogenic effect of melittin via mitigating TLR4/TRAF6 mediated NF-κB and p38MAPK pathways in acetic acid-induced ulcerative colitis in mice[J]. Chem Biol Interact, 2020, 331:109276. doi: 10.1016/j.cbi.2020.109276.
[28]	KRISHNAN M, CHOI J, JANG A, et al. Molecular mechanism underlying the TLR4 antagonistic and antiseptic activities of Papiliocin, an insect innate immune response molecule[J]. Proc Natl Acad Sci U S A, 2022, 119(10):e2115669119. doi: 10.1073/pnas.2115669119.
[29]	LI B, YANG N, SHAN Y, et al. Therapeutic potential of a designed CSαβ peptide ID13 in Staphylococcus aureus-induced endometritis of mice[J]. Appl Microbiol Biotechnol, 2020, 104(15):6693-6705. doi: 10.1007/s00253-020-10685-x.
[30]	ALHARBI K S, FULORIA N K, FULORIA S, et al. Nuclear factor-kappa B and its role in inflammatory lung disease[J]. Chem Biol Interact, 2021, 345:109568. doi: 10.1016/j.cbi.2021.109568.
[31]	PRESCOTT J A, MITCHELL J P, COOK S J. Inhibitory feedback control of NF-κB signalling in health and disease[J]. Biochem J, 2021, 478(13):2619-2664. doi: 10.1042/BCJ20210139.
[32]	PARK H J, LEE S H, SON D J, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit[J]. Arthritis Rheum, 2004, 50(11):3504-3515. doi: 10.1002/art.20626.
[33]	ZHAO X, WANG L, ZHU C, et al. The antimicrobial peptide Mastoparan X protects against enterohemorrhagic Escherichia coli O157: H7 infection, inhibits inflammation, and enhances the intestinal epithelial barrier[J]. Front Microbiol, 2021, 12:644887. doi: 10.3389/fmicb.2021.644887.
[34]	JEONG Y J, SHIN J M, BAE Y S, et al. Melittin has a chondroprotective effect by inhibiting MMP-1 and MMP-8 expressions via blocking NF-κB and AP-1 signaling pathway in chondrocytes[J]. Int Immunopharmacol, 2015, 25(2):400-405. doi: 10.1016/j.intimp. 2015. 02. 021.
[35]	LIU Y, PERUMALSAMY H, KANG C H, et al. Intracellular synthesis of gold nanoparticles by Gluconacetobacter liquefaciens for delivery of peptide CopA3 and ginsenoside and anti-inflammatory effect on lipopolysaccharide-activated macrophages[J]. Artif Cells Nanomed Biotechnol, 2020, 48(1):777-788. doi: 10.1080/21691401.2020.1748639.
[36]	SHIN Y P, LEE J H, CHOI R Y, et al. Antiseptic effect of antimicrobial peptide Psacotheasin 2 derived from the yellow-spotted longicorn beetle (Psacothea hilaris)[J]. Dev Comp Immunol, 2021, 123:104140. doi: 10.1016/j.dci.2021.104140.
[37]	KIM I W, LEE J H, SEO M, et al. Anti-inflammatory activity of antimicrobial peptide Periplanetasin-5 derived from the cockroach Periplaneta americana[J]. J Microbiol Biotechnol, 2020, 30(9):1282-1289. doi: 10.4014/jmb.2004.04046.
[38]	SHIN Y P, LEE J H, KIM I W, et al. Anti-inflammatory activity of antimicrobial peptide Zophobacin 1 derived from the Zophobas atratus[J]. J Life Sci, 2020, 30(9):804-812.doi: 10.5352/JLS.2020.30.9.804.
[39]	KASSOUF T, SUMARA G. Impact of conventional and atypical MAPKs on the development of metabolic diseases[J]. Biomolecules, 2020, 10(9):1256. doi: 10.3390/biom10091256.
[40]	WANG Z, GOU X. Receptor-like protein kinases function upstream of MAPKs in regulating plant development[J]. Int J Mol Sci, 2020, 21(20):7638. doi: 10.3390/ijms21207638.
[41]	SEO M, SHIN Y P, LEE H J, et al. Anti-neuroinflammatory effect of Teleogryllus emma derived Teleogryllusine in LPS-stimulated BV-2 microglia[J]. J Life Sci, 2020, 30(11):999-1006. doi: 10.5352/JLS.2020.30.11.999
[42]	WANG L, HU Y, SONG B, et al. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease[J]. Inflamm Res, 2021, 70(7):753-764. doi: 10.1007/s00011-021-01482-x.
[43]	LI B, WAN Q, LI Z, et al. Janus kinase signaling:oncogenic criminal of lymphoid cancers[J]. Cancers (Basel), 2021, 13(20):5147. doi: 10.3390/cancers13205147.
[44]	AN H J, KIM J Y, KIM W H, et al. Therapeutic effects of bee venom and its major component, melittin, on atopic dermatitis in vivo and in vitro[J]. Br J Pharmacol, 2018, 175(23):4310-4324. doi: 10.1111/bph.14487.
[45]	KIM K H, SUNG H J, LEE W R, et al. Effects of melittin treatment in cholangitis and biliary fibrosis in a model of xenobiotic-induced cholestasis in mice[J]. Toxins(Basel), 2015, 7(9):3372-3387. doi: 10.3390/toxins7093372.
[46]	NAM H J, OH A R, NAM S T, et al. The insect peptide CopA3 inhibits lipopolysaccharide-induced macrophage activation[J]. J Pept Sci, 2012, 18(10):650-656. doi: 10.1002/psc.2437.
[47]	YOON I N, HONG J, ZHANG P, et al. An analog of the antimicrobial peptide CopA5 inhibits lipopolysaccharide-induced macrophage activation[J]. J Microbiol Biotechnol, 2017, 27(2):350-356. doi: 10.4014/jmb.1607.07065.
[48]	WANG M, ZHANG J, GONG N. Role of the PI3K/Akt signaling pathway in liver ischemia reperfusion injury : a narrative review[J]. Ann Palliat Med, 2022, 11(2):806-817. doi: 10.21037/apm-21-3286.
[49]	DARICI S, ALKHALDI H, HORNE G, et al. Targeting PI3K/Akt/mTOR in AML:rationale and clinical evidence[J]. J Clin Med., 2020, 9(9):2934. doi: 10.3390/jcm9092934.
[50]	KIM W H, AN H J, KIM J Y, et al. Anti-inflammatory effect of melittin on Porphyromonas gingivalis LPS-stimulated human keratinocytes[J]. Molecules, 2018, 23(2):332. doi: 10.3390/molecules23020332.
[51]	GU H, AN H J, GWON M G, et al. Bee venom and its major component melittin attenuated Cutibacterium acnes- and IGF-1-induced acne vulgaris via inactivation of Akt/mTOR/SREBP signaling pathway[J]. Int J Mol Sci, 2022, 23(6):3152. doi: 10.3390/ijms23063152.
[52]	FAN X G, PEI S Y, ZHOU D, et al. Melittin ameliorates inflammation in mouse acute liver failure via inhibition of PKM2-mediated Warburg effect[J]. Acta Pharmacol Sin, 2021, 42(8):1256-1266. doi: 10.1038/s41401-020-00516-0.
[53]	MOON D O, PARK S Y, LEE K J, et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia[J]. Int Immunopharmacol, 2007, 7(8):1092-1101. doi: 10.1016/j.intimp.2007.04.005.
[54]	ZHANG T, WANG X F, WANG Z C, et al. Current potential therapeutic strategies targeting the TGF-β/Smad signaling pathway to attenuate keloid and hypertrophic scar formation[J]. Biomed Pharmacother, 2020, 129:110287. doi: 10.1016/j.biopha.2020.110287.
[55]	LI S N, WU J F. TGF-β/Smad signaling regulation of mesenchymal stem cells in adipocyte commitment[J]. Stem Cell Res Ther, 2020, 11(1):41. doi: 10.1186/s13287-020-1552-y.
[56]	SHIN S H, YE M K, CHOI S Y, et al. The effects of melittin and apamin on airborne fungi-induced chemical mediator and extracellular matrix production from nasal polyp fibroblasts[J]. Toxins(Basel), 2017, 9(11):348. doi: 10.3390/toxins9110348.
[57]	LEE J, HAN S Y, JI A R, et al. Antimicrobial effects of coprisin on wounds infected with Staphylococcus aureus in rats[J]. Wound Repair Regen, 2013, 21(6):876-882. doi: 10.1111/wrr.12112.
[58]	CHEN C H, LU T K. Development and challenges of antimicrobial peptides for therapeutic applications[J]. Antibiotics(Basel), 2020, 9(1):24. doi: 10.3390/antibiotics9010024.
[59]	CARPENA M, NUNEZ-ESTEVEZ B, SORIA-LOPEZ A, et al. Bee venom: an updating review of its bioactive molecules and its health applications[J]. Nutrients, 2020, 12(11):3360. doi: 10.3390/nu12113360.
[60]	ASKARI P, NAMAEI M H, GHAZVINI K, et al. In vitro and in vivo toxicity and antibacterial efficacy of melittin against clinical extensively drug-resistant bacteria[J]. BMC Pharmacol Toxicol, 2021, 22(1):42. doi: 10.1186/s40360-021-00503-z.
[61]	LUONG H X, THANH T T, TRAN T H. Antimicrobial peptides-advances in development of therapeutic applications[J]. Life Sci, 2020, 260:118407. doi: 10.1016/j.lfs.2020.118407.